Table 1. Demographics and clinical data of untreated patients with relapse remitting multiple sclerosis (RRMS), RRMS patients treated with fingolimod (Fingo), and controls.
| CSF | |||
|---|---|---|---|
| Control | RRMS-Untreated | RRMS-Fingo | |
| Number of subjects | 10 | 14 | 16 |
| Gender (M:F) | 1:2 | 5:9 | 3:13 |
| Age in years (range) | 38 (21-59) | 33 (18-59) | 42 (23-62) |
| Period under fingolimod medication, in years (range) | NA | NA | 3 (0.6-5.5) |
| EDSS (range) | NA | 2.2 (1-6.5) | 2.4 (1.5-6.5) |
| Period after diagnosis, in years (range) | NA | 3.8 (0.1-17) | 7.9 (3.5-15) |
EDSS: Expanded Disability Status Scale; NA: not applicable.